Mylan’s Australia unit is appealing decisions by the tax office to refuse deductions on interest paid under loans taken out by the pharmaceutical giant to help fund the $1.2 billion acquisition of generic drug maker Alphapharm almost 15 years ago.
The world’s No. 1 men’s tennis player Novak Djokovic has won a court challenge to the cancellation of his visa, with a judge ordering his immediate release from detention.
Class action settlement totals skyrocketed to over $900 million last year, and one law firm negotiated the lion’s share, with $672 million in settlements under its belt.
Bayer has lost its bid to redact the names and contact details of potential group members from discovered documents in a Slater & Gordon-led class action over the drug maker’s Essure contraceptive device.
The Transport Workers Union has appealed a judge’s decision that compensation was a more appropriate remedy for 1,800 Qantas workers who had been denied the “matchless blessing” of a job than reinstatement.
A group of banks that failed to prove steel giant Arrium falsified representations on loan drawdown notices ahead of its $2.8 billion collapse have been ordered to pay indemnity costs after a court found they rejected $10 million settlement offers three days into the trial.
The maker of the popular Invisalign dental aligners has sued competitor SmileDirectClub for allegedly misleading consumers about the cost and efficacy of its direct-to-consumer teeth alignment kits.
Superannuation provider Statewide Super has been ordered to pay a $4 million penalty for an administrative error that saw around 12,500 fund members charged for insurance they did not receive.
A Fairfax journalist and his employer have been ordered to pay $400,000 for making “baseless” accusations of fraud and unethical market manipulation against the co-founder of an Australian blockchain-based energy trading platform.
Dixon Advisory faces a second class action on behalf of investors who claim they suffered significant financial loss when the advice firm and its directors allegedly encouraged the purchase of high risk, high fee securities for their own financial gain.